ArticlePloS one2019

Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis.

Nao Tokai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.